24 filings
8-K
NPTX
Neuropathix, Inc.
24 Mar 22
Entry into a Material Definitive Agreement
8:17pm
8-K
NPTX
Neuropathix, Inc.
28 Sep 21
Regulation FD Disclosure
9:00am
8-K
NPTX
Neuropathix, Inc.
17 Mar 21
Departure of Directors or Certain Officers
4:00pm
8-K
NPTX
Neuropathix, Inc.
23 Feb 21
Entry into a Material Definitive Agreement
4:01pm
8-K
NPTX
Neuropathix, Inc.
21 Dec 20
Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate
4:57pm
8-K
kbmjaiku30h 6f
19 Nov 20
Neuropathix, Inc. Signs Binding Letter of Intent to Acquire Anticonvulsant – Neuroprotective Intellectual Property
9:00am
8-K
g30gei9l
6 Nov 20
Kannalife, Inc. Rebrands as Neuropathix, Inc.; Reveals New Name, Ticker Symbol, Updated Logo and Visual Identity
6:29am
8-K
5pix6 w6o894ny6ap
22 Sep 20
Entry into a Material Definitive Agreement
2:33pm
8-K
d8iv9j7woizd6
29 Jun 20
Entry into a Material Definitive Agreement
12:00am
8-K
n8qxhuwrir5uvdbqyoo
11 Jun 20
Entry into a Material Definitive Agreement
5:23pm
8-K
9twueylxb98dw2zp4n
10 Apr 20
Entry into a Material Definitive Agreement
12:39pm
8-K
80jguwlku3u3q
10 Apr 20
Changes in Control of Registrant
12:36pm
8-K
7geg7p
18 Mar 20
Entry into a Material Definitive Agreement
5:04pm
8-K
kmhmv7p
28 Jan 20
Regulation FD Disclosure
9:00am
8-K
lrinl 0pona
5 Oct 18
Changes in Registrant's Certifying Accountant
3:39pm
8-K/A
yx6l8c710jx2w7ce0gx
2 Oct 18
Index to Financial Statements
5:17pm
8-K
1a89sbigotpcod
31 Jul 18
Kannalife Sciences Finalizes Share Exchange Agreement
5:16pm
8-K
nghfxb22fmh8al8n7yhp
30 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K/A
h36v7fnq3dlb7ul wp
25 May 18
Material Modifications to Rights of Security Holders
1:03pm
8-K
bzta q9u5qwq
4 May 18
Material Modifications to Rights of Security Holders
5:29pm